Drug firm Dr Reddy's Laboratories today reported a 56.61 per cent dip in its consolidated net profit to Rs 66.6 crore for the quarter ended June, mainly on account of lower revenues from the US and impact of GST in India.
The company had posted a net profit after taxes and share of profit of associates of Rs 153.5 crore for the same period of the previous fiscal, Dr Reddy's Laboratories said in a BSE filing.
Consolidated net sales of the company stood at Rs 3,248.9 crore for the quarter under consideration. It stood at Rs 3,185.7 crore for the corresponding period a year ago.
Shares of Dr Reddy's Laboratories were today trading 2.40 per cent lower at Rs 2,645.50 per scrip on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
